AI assistant
EVERSPIN TECHNOLOGIES INC. — Director's Dealing 2023
Mar 8, 2023
33680_dirs_2023-03-07_b17bff24-3315-4828-8cbb-f478a4cd6a3e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: EVERSPIN TECHNOLOGIES INC (MRAM)
CIK: 0001438423
Period of Report: 2023-02-28
Reporting Person: Schrenk David (VP Sales and Business)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 24609 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.52 | 2028-08-19 | Common Stock (2110) | Direct | |
| Stock Option (Right to Buy) | $6.86 | 2029-08-25 | Common Stock (3057) | Direct | |
| Stock Option (Right to Buy) | $2.23 | 2030-03-23 | Common Stock (7292) | Direct | |
| Stock Option (Right to Buy) | $2.56 | 2030-04-06 | Common Stock (1209) | Direct | |
| Stock Option (Right to Buy) | $5.62 | 2031-08-05 | Common Stock (12500) | Direct | |
| Stock Option (Right to Buy) | $8.17 | 2032-03-13 | Common Stock (15000) | Direct |
Footnotes
F1: Includes 22,043 shares subject to unvested restricted stock units.
F2: Fully vested.
F3: The option vested as to 25% of the shares on August 26, 2020, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on August 26, 2023. The original grant was for 6,986 shares, of which 3,929 shares have been exercised.
F4: The option vested as to 25% of the shares on March 24, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 24, 2024. The original grant was for 12,500 shares, of which 5,208 shares have been exercised.
F5: The option vested as to 25% of the shares on April 7, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on April 7, 2024. The original grant was for 2,000 shares, of which 791 shares have been exercised.
F6: The option vested as to 25% of the shares on March 10, 2022, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 10, 2025.
F7: The option vested as to 25% of the shares on February 28, 2023, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on February 28, 2026.